4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR US NUCLEAR MEDICINE, BY KEY PLAYER (2024)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON US NUCLEAR MEDICINE
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN US NUCLEAR MEDICINE MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN US NUCLEAR MEDICINE MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
US NUCLEAR MEDICINE MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
9.2
DIAGNOSTIC NUCLEAR MEDICINE
9.2.1
SPECT RADIOISOTOPES
9.2.1.5
OTHER SPECT ISOTOPES
9.2.2.3
OTHER PET ISOTOPES
9.3
THERAPEUTIC NUCLEAR MEDICINE
9.3.2.6
OTHER BETA EMITTERS
9.3.3
BRACHYTHERAPY ISOTOPE
9.3.3.5
OTHER BRACHYTHERAPY ISOTOPES
10
US NUCLEAR MEDICINE MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
10.2
DIAGNOSTIC APPLICATIONS
10.2.1
SPECT APPLICATIONS
10.2.1.5
OTHER SPECT APPLICATIONS
10.2.2.4
OTHER PET APPLICATIONS
10.3
THERAPEUTIC APPLICATIONS
10.3.1
THYROID INDICATIONS
10.3.5
OTHER THERAPEUTIC APPLICATIONS
11
US NUCLEAR MEDICINE MARKET, BY VOLUME ASSESSMENT (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
11.2
DIAGNOSTIC PROCEDURES
11.3
THERAPEUTIC PROCEDURES
12
US NUCLEAR MEDICINE MARKET, BY END USER (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
12.4
ACADEMIC & RESEARCH CENTERS
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
13.3
REVENUE ANALYSIS (2020-2024)
13.4
MARKET SHARE ANALYSIS (2024)
13.5
BRAND/SOFTWARE COMPARATIVE ANALYSIS
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.6.5.1
COMPANY FOOTPRINT
13.6.5.2
REGION FOOTPRINT
13.6.5.4
APPLICATION FOOTPRINT
13.6.5.5
VOLUME ASSESSMENT FOOTPRINT
13.6.5.6
END USER FOOTPRINT
13.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
13.7.1
PROGRESSIVE COMPANIES
13.7.3
RESPONSIVE COMPANIES
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
13.8
COMPANY VALUATION AND FINANCIAL METRICS
13.9
COMPETITIVE SCENARIOS
13.9.1
PRODUCT LAUNCHES & UPGRADES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE MARKET LANDSCAPE
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
15.1.1.3.1
KEY STRENGTHS/RIGHT TO WIN
15.1.1.3.2
STRATEGIC CHOICES
15.1.1.3.3
WEAKNESS/COMPETITIVE THREATS
14.1.5
LANTHEUS HOLDINGS, INC.
14.1.7
JUBILANT PHARMOVA LIMITED
14.1.8
BRACCO IMAGING S.P.A
14.1.9
PHARMALOGIC HOLDINGS CORP.
14.1.10
SUN PHARMACEUTICAL INDUSTRIES, INC.
14.1.12
SIEMENS HEALTHINEERS AG
14.1.13
NORTHSTAR MEDICAL RADIOISOTOPES, LLC
14.1.15
ACTINIUM PHARMACEUTICALS, INC.
14.1.16
GLOBAL MEDICAL SOLUTIONS
14.1.17
TELIX PHARMACEUTICALS LIMITED.
14.1.18
PDRADIOPHARMA INC.
14.1.19
ITM ISOTOPE TECHNOLOGIES MUNICH SE
14.1.20
BWX TECHNOLOGIES INC.
14.2.1
SHINE TECHNOLOGIES, LLC
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
15.1.2.2
KEY PRIMARY PARTICIPANTS
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.4
KEY INDUSTRY INSIGHTS
15.2
MARKET SIZE ESTIMATION
15.2.1
BOTTOM-UP APPROACH
15.2.3
BASE NUMBER CALCULATION
15.3
MARKET FORECAST APPROACH
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
CUSTOMIZATION OPTIONS
THE SEGMENTATION GIVEN MAY CHANGE DEPENDING ON RESEARCH FINDINGS.
THE LIST OF COMPANIES MENTIONED ABOVE IS INDICATIVE ONLY AND MAY CHANGE AS PER FURTHER RESEARCH FINDINGS. KEY 25 COMPANIES WILL BE PROFILED IN THIS SECTION. DETAILS ON OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT MIGHT NOT BE CAPTUR
Growth opportunities and latent adjacency in US Nuclear Medicine Market